Get the tools used by (smart)2 investors.

Restructuring Charges for Zimmer Biomet Holdings Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ZBH: Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, suc...

99.45 USD
Price
USD
Fair Value
Upside
93.10 - 123.96
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Zimmer Biomet Holdings Inc's Restructuring Charges:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-250 M-200 M-150 M-100 M-50 M0 K

Performance Summary
  • Zimmer Biomet's latest twelve months restructuring charges is -230.5 million
  • Zimmer Biomet's restructuring charges for fiscal years ending December 2020 to 2024 averaged -163 million.
  • Zimmer Biomet's operated at median restructuring charges of -160.1 million from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Zimmer Biomet's restructuring charges peaked in December 2020 at -107.2 million.
  • Zimmer Biomet's restructuring charges hit its 5-year low in December 2024 of -230.5 million.
  • Zimmer Biomet's restructuring charges decreased in 2020 (-107.2 million, +114.4%), 2021 (-125.7 million, +17.3%), 2022 (-191.6 million, +52.4%), and 2024 (-230.5 million, +44.0%) and increased in 2023 (-160.1 million, -16.4%).

Benchmarks

Metric Usage: Restructuring Charges

Hide this widget
restructure
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Restructuring Charges in the financials category include:

  • Interest Capitalized - Interest expense that has been capitalized as an asset and is amortized over a defined period.
  • Current Portion of LT Debt - The portion of long term debt which is due in the upcoming year.
  • Other Operating Expenses, Total - This item represents the other operating costs incurred during the given fiscal year.
  • Net Income to Company - This item represents the net income available to all stakeholders of the company and is presented as total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
View Full List

Search for metric or datapoint

Restructuring Charges

Expenses incurred from reorganizing a company's internal operational architecture or debt structure.

Definition of Restructuring Charges

Hide this widget

Zimmer Biomet reported restructuring charges of -230.5 M for the latest twelve months ending December 31, 2024 on its income statement.

The tables below summarizes Zimmer Biomet’s Restructuring Charges and common size over the last five years:

Fiscal YearRestructuring ChargesRevenue% Revenue
2020-12-31-107.2 M6.128 B−1.7%
2021-12-31-125.7 M6.827 B−1.8%
2022-12-31-191.6 M6.94 B−2.8%
2023-12-31-160.1 M7.394 B−2.2%
2024-12-31-230.5 M7.679 B−3.0%

The tables below summarizes Zimmer Biomet’s Restructuring Charges and common size over the last four quarters:

Quarter EndingRestructuring ChargesRevenue% Revenue
2024-03-31-124.4 M1.889 B−6.6%
2024-06-30-41.8 M1.942 B−2.2%
2024-09-30-39.9 M1.824 B−2.2%
2024-12-31-23.8 M2.023 B−1.2%

Click the link below to download a spreadsheet with an example Restructuring Charges calculation for Zimmer Biomet Holdings Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-36.014 M-21.014 M-6.014 M11.99 M04080

The chart above depicts the distribution of restructuring charges for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 232 had meaningful values. The average restructuring charges of companies in the sector is -4.022 M with a standard deviation of 6.943 M.

Zimmer Biomet Holdings Inc's Restructuring Charges of -230.5 M is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Restructuring Charges In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents3,180
Included Constituents232
Min-34.871 M
Max10.847 M
Median-1.3 M
Mean-4.022 M
Standard Deviation6.943 M

You can find companies with similar restructuring charges using this stock screener.

All rights reserved. Terms Of Use